Cantor Fitzgerald Maintains Overweight on CVRx, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 91.4%

Neg 91.4% Neu 0% Pos 0%

Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $13 to $5.